2nd Circ. Gives New Life To DDAVP Antitrust Case

Law360, New York (October 19, 2009, 5:23 PM EDT) -- The U.S. Court of Appeals for the Second Circuit has overturned a lower court's dismissal of an antitrust case alleging that Ferring Pharmaceuticals Inc. and Aventis Pharmaceuticals Inc. conspired to keep generic drugs off the shelves by fraudulently acquiring a patent for diabetes drug DDAVP.

The Second Circuit on Friday vacated and remanded a ruling handed down by the late Judge Charles Brieant of the U.S. District Court for the Southern District of New York in November 2006, giving the plaintiffs another shot to pursue their...
To view the full article, register now.